Skip to main content
. 2019 Mar 19;11(3):272. doi: 10.3390/v11030272

Table 1.

Protective and pathologic tissue-resident lymphocyte responses to viral infection.

Cell Type Virus Protection or Pathogenesis Genetic Evidence * Redundancy Reference
ILC1 MCMV Protection Yes No [7]
ILC1 Influenza A (H1N1) Protection No ? [8]
ILC1 Adenovirus, LCMV Protection No ? [9,10]
ILC2 Influenza A (H1N1) Pathogenesis No ? [11]
ILC2 Influenza A (H1N1) Protection No ? [13]
ILC2 Influenza A (H1N1) Protection No ? [15]
ILC2 Influenza A (H3N1) Pathogenesis No ? [18]
ILC2 Rhinovirus Pathogenesis No ? [19]
ILC2 RSV Pathogenesis No ? [20]
ILC3 Rotavirus Protection No ? [23]
ILC3 SIV Protection No ? [24,25,26]
ILC3 Adenovirus, LCMV Pathogenesis No ? [29]
ILC3 Chronic HBV Pathogenesis No ? [30,31]
iNKT Influenza A (PR8) Protection Yes No [36]
iNKT RSV Protection No ? [37]
iNKT MCMV Protection Yes Yes [43]
iNKT Influenza A Protection No ? [44,45]
iNKT Influenza A (H1N1) Protection No ? [46]
iNKT Chronic HBV, HCV Neither No ? [47,48]
MAIT Dengue, HCV, Influenza Both No ? [56]
MAIT Influenza A (H1N1) Protection Yes No [58]
MAIT HIV Protection No ? [61]
γδ HHV Protection No ? [70,71]
γδ Vaccinia, West Nile Protection Yes No [72,73]
γδ MCMV Protection Yes Yes [78,79]
γδ HIV Pathogenesis No ? [81]
γδ Influenza A (H1N1, H5N1) Protection Yes No [82]

* Genetic evidence refers to the specific ablation of the indicated cell type in the presence of an intact immune system. ? refers to incomplete evidence for subset redundancy in the referenced study. ILC: Innate lymphoid cell. MCMV: Murine Cytomegalovirus. LCMV: Lymphocytic Choriomeningitis Virus. RSV: Respiratory Syncytial Virus. HBV: Hepatitis B Virus. SIV: Simian Immunodeficiency Virus. iNKT: invariant Natural killer T cell. HCV: Hepatitis C Virus. NKT: Natural killer T cell. MAIT: Mucosal associated invariant T cell. γδ: γδ T cell. HHV: Human Herpesvirus. HIV: Human Immunodeficiency Virus.